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ABSTRACT Chikungunya virus (CHIKV) and Zika virus (ZIKV) emerged in the Ameri-
cas in 2013. Limited antigenic variability of CHIKV and ZIKV may restrict urban trans-
mission cycles due to population protective immunity. In Africa, sylvatic transmission
cycles involving nonhuman primates (NHP) are known for CHIKV and ZIKV, causing
cyclic reemergence in humans. To evaluate whether sylvatic cycles can be expected
in Latin America, we tested 207 NHP collected between 2012 and 2017 in urban and
peri-urban settings in Brazil for infection with ZIKV and CHIKV. No animal tested pos-
itive for viral RNA in genus-speciﬁc and species-speciﬁc reverse transcription-PCR
(RT-PCR) assays. In contrast, six animals (2.9%) from the families Atelidae, Callitrichi-
dae, and Cebidae showed ZIKV-speciﬁc antibodies and 11 (5.3%) showed CHIKV-
speciﬁc antibodies in plaque reduction neutralization tests (PRNT). Reactivity was
monotypic against either ZIKV or CHIKV in all cases, opposing unspeciﬁc virucidal ac-
tivity of sera. PRNT endpoint titers were low at 1:40 in all NHP, and positive speci-
mens did not correspond to the likely dispersal route and time of introduction of
both arboviruses. All antibody-positive samples were therefore tested against the
NHP-associated yellow fever virus (YFV) and Mayaro virus (MAYV) and against the
human-associated dengue virus (DENV) by PRNT. Two ZIKV-positive samples were
simultaneously DENV positive and two CHIKV-positive samples were simultaneously
MAYV positive, at titers of 1:40 to 1:160. This suggested cross-reactive antibodies
against heterologous alphaviruses and ﬂaviviruses in 24% of ZIKV-positive/CHIKV-
positive sera. In sum, low seroprevalence, invariably low antibody titers, and the dis-
tribution of positive specimens call into question the capability of ZIKV and CHIKV to
infect New World NHP and establish sylvatic transmission cycles.
IMPORTANCE Since 2013, Zika virus (ZIKV) and chikungunya virus (CHIKV) have in-
fected millions of people in the Americas via urban transmission cycles. Nonhuman
primates (NHP) are involved in sylvatic transmission cycles maintaining ZIKV and
CHIKV in the Old World. We tested NHP sampled during 2012 to 2017 in urban and
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peri-urban areas severely affected by ZIKV and CHIKV in Brazil. Seroprevalence and
antibody titers were low for both viruses. Additionally, we found evidence for infec-
tion by heterologous viruses eliciting cross-reactive antibodies. Our data suggest
that urban or peri-urban NHP are not easily infected by ZIKV and CHIKV despite in-
tense local transmission. These data may imply that the ZIKV and CHIKV outbreaks
in the Americas cannot be sustained in urban or peri-urban NHP once human popu-
lation immunity limits urban transmission cycles. Investigation of diverse animals is
urgently required to determine the fate of the ZIKV and CHIKV outbreaks in the
Americas.
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The Zika virus (ZIKV) is a member of the genus Flavivirus in the family Flaviviridae,whereas the chikungunya virus (CHIKV) is a member of the genus Alphavirus in the
family Togaviridae. Both arthropod-borne viruses (arboviruses) originated in Africa and
were likely introduced into Brazil during 2013, affecting millions of individuals since
then (1, 2). The ZIKV circulating in Latin America belongs to the Asian lineage (2). For
CHIKV, two separate introductions into Brazil took place. The Asian lineage was
introduced in 2013, whereas the eastern, central, and southern African (ECSA) lineage
was introduced independently in 2014 (3).
Similarly to the human-associated dengue virus (DENV), the American ZIKV and
CHIKV epidemics rely on urban transmission cycles involving predominantly urban
Aedes aegypti mosquito vectors and humans as vertebrate hosts (4). However, unlike
DENV, ZIKV and CHIKV show limited antigenic variability (5, 6). This implies that
population immunity following extensive spread in humans may cause the outbreak to
stop (7).
In Africa, ZIKV and CHIKV are likely maintained during interepidemic phases in
sylvatic transmission cycles involving nonhuman primates (NHP) and forest-associated
mosquitoes (8, 9). Which NHP species are involved in these sylvatic transmission cycles
is not entirely clear. For ZIKV, seroprevalence of up to 16% hints at frequent exposure
of yellow baboons (Papio cynocephalus) and African green monkeys (Chlorocebus
pygerythrus) (10). For CHIKV, virus has been isolated from tantalus monkeys (Cercopith-
ecus aethiops tantalus), patas monkeys (Erythrocebus patas), Guinea baboons (Papio
papio) (11), and green monkeys (Chlorocebus sabaeus) (12). A high seroprevalence of
72% in these NHP species according to a non-peer-reviewed preprint suggests frequent
exposure of these species to CHIKV (13). Blood meal analyses of mosquito vectors
competent for ZIKV and CHIKV show preferences for feeding on green monkeys and
Guinea baboons (14), which is consistent with evidence for ZIKV or CHIKV infection in
these and genetically related NHP species. In Asia, whether and which NHP species are
involved in ZIKV and CHIKV transmission cycles is unclear, albeit preliminary evidence
hints at infection of different macaque species (15–17).
Similarly, which invertebrate species maintain ZIKV and CHIKV sylvatic transmission
cycles in the Old World is not entirely clear. In Africa, potential ZIKV vectors include
Aedes africanus, Aedes albopictus, Aedes apicoargenteus, and Aedes furcifer (17–19).
CHIKV has been detected in numerous mosquito species, including A. aegypti, A. afri-
canus, Aedes luteocephalus, and Aedes furcifer-taylori (20). For Asia, the available data on
invertebrate hosts sustaining potential sylvatic transmission cycles are scarce.
The ability to extrapolate data from the Old World to potential vertebrate and
invertebrate hosts potentially maintaining sylvatic transmission cycles in the Americas
is limited. Old World primates (the Catarrhini) comprise the superfamilies Hominoidea,
including humans, and Cercopithecoidea (21). Evidence for the ability of ZIKV and
CHIKV to infect representatives of both superfamilies may imply a relatively broad host
range of these emerging arboviruses within Old World primates. Because New World
NHP (the Platyrrhini) arose from Old World ancestors about 36 million years ago (22),
susceptibility to ZIKV and CHIKV may be a broadly conserved trait. However, differential
susceptibility of New World NHP to yellow fever virus (YFV) illustrates that individual
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assessments will be required to identify candidate NHP species potentially maintaining
ZIKV and CHIKV in the Americas.
On the vector side, Aedes species may be among the prime suspects for potential
sylvatic transmission cycles. Brazil has approximately 28 Aedes species that have only
very limited overlap with Old World Aedes species other than the widespread A. aegypti
and A. albopictus (23). Indeed, experimental data revealed that Aedes terrens mosqui-
toes, a known vector in American YFV sylvatic transmission cycles, are highly compe-
tent for CHIKV (24). However, the YFV vector Haemagogus leucocelaenus showed
similarly high competence for CHIKV (24), illustrating that potential invertebrate hosts
need not be restricted to the genus Aedes. Unfortunately, conclusive evidence for
vector competence of Neotropical forest-associated mosquito species for ZIKV is scarce
to date.
Despite the lack of experimental data, it has been suggested that ZIKV and CHIKV
will be able to explore sylvatic cycles in Latin America. The rationale underlying these
predictions includes the high number of mosquito and NHP species and their large
population sizes in Latin America, as well as the relatively close contact between NHP
and humans (25, 26). Another argument that may support an introduction of ZIKV and
CHIKV into American NHP is the large die-offs of NHP documented in Brazil during 2016
to 2017, including several species deemed to be robust against YFV, which is a known
pathogen of Neotropical NHP (27). Therefore, a report on very high ZIKV detection rates
in marmosets (Callithrix jacchus) and capuchin monkeys (Sapajus libidinosus), available
only as a non-peer-reviewed preprint so far, attracted substantial attention in the
scientiﬁc community and the media (28).
Here, we tested NHP from urban and peri-urban environments showing intense
human ZIKV and CHIKV transmission in northeastern and central-western Brazil by
molecular and serological methods. Using sera collected before and after the projected
introduction of ZIKV and CHIKV into Brazil, we ﬁnd limited evidence for exposure of
Neotropical NHP to these emerging arboviruses.
RESULTS
Samples from 207 NHP were either obtained from local repositories or prospectively
sampled in three Brazilian zoos located in the 2.7-million-inhabitant metropolis Salva-
dor and the 2.4-million-inhabitant capital Brasília and from Itapetinga, a northeastern
municipality with 75,000 inhabitants. Additional sampling sites were national primate
centers in Cabedelo, Salvador, Vitória da Conquista, and Barreiras, as well as urban and
peri-urban sites (within 10 km of the city) in northeastern and central-western Brazil,
namely, Lucena, Sapé, and Santa Rita, where free-ranging animals were sampled
(Table 1; Fig. 1). The samples analyzed in this study represent sampling sites spread
across 1,700 km in northeastern and central-western Brazil (Fig. 1). The sampled areas
overlap with the areas to which ZIKV and CHIKV were likely introduced upon their
arrival in mainland southern America and which showed intense circulation of ZIKV and
CHIKV in humans (1, 2). The sample represented 25 NHP species, covering about 20%
and all ﬁve families of NHP species found in Latin America (Table 1).
No specimen tested positive for viral RNA in genus-speciﬁc nested reverse
transcription-PCR (RT-PCR) assays targeting the genera Flavivirus and Alphavirus (29, 30)
or in highly sensitive strain-speciﬁc real-time RT-PCR assays for ZIKV and CHIKV (31, 32).
This suggested the absence of acute infection with ZIKV and CHIKV or other ﬂaviviruses
or alphaviruses in all animals.
In contrast, six animals showed neutralizing antibodies against ZIKV (2.9%). Notice-
ably, two of these animals were sampled as early as the projected introduction of ZIKV
into Brazil in 2013 (Table 2) (33). For CHIKV, we found 11 animals with neutralizing
antibodies (5.3%), sampled in 2013 to 2014 and 2016, which again overlaps with the
time of the likely introduction of CHIKV into northeastern Brazil (2). Seroprevalence
rates for ZIKV and CHIKV did not differ signiﬁcantly (Fisher’s exact test, P  0.05).
Seropositive animals belonged to the Atelidae, Callitrichidae, and Cebidae families,
which were also the most abundantly sampled families in this study (Table 1). Sero-
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prevalence for ZIKV and CHIKV in Atelidae was 12.5% (3/24) and 4.1% (1/24); in Cebidae,
it was 1.4% (2/142) and 6.3% (6/142), respectively; and in Callitrichidae, it was 2.9%
(1/34) for both viruses. No signiﬁcant difference in the seroprevalence between families
was observed for CHIKV (Fisher’s exact test, P  0.05). For ZIKV, only the 12.5%
seroprevalence within Atelidae differed signiﬁcantly from the 1.4% seroprevalence
within Cebidae (Fisher’s exact test, P  0.02). Hypothetically, the relatively higher ZIKV
seroprevalence in Atelidae may result from differences in the ZIKV-associated mortality
between different NHP species, as observed with YFV (34). However, recent studies
reported a complete absence of severe disease in different NHP species experimentally
infected with ZIKV, albeit the small numbers of infected animals suggest that caution
must be used in drawing deﬁnite conclusions on ZIKV-associated disease in NHP (35,
36). Alternatively, Atelidae may be more exposed to ZIKV than other NHP families due
to differences in feeding preferences of mosquito vectors. However, a sample bias
cannot be excluded at this point, even though Atelidae from three different sampling
sites spread across750 km tested positive (Table 2). In sum, whether Atelidae may be
more exposed to ZIKV than other NHP families remains to be determined.
TABLE 1 Sample characteristicsa
Family and speciesb





speciesa b c d e f g h i
Aotidae (4)
Aotus nigriceps 0 0 0 0 0 0 0 0 4 4 2017 (i)
Atelidae (24)
Alouatta caraya 0 0 0 0 0 0 1 0 6 7 2016 (g)/2017 (i)
Alouatta belzebul 1 1 0 1 0 0 0 0 3 6 2013 (d)/2014 (a, b)/2017 (i)
Alouatta seniculus 0 0 0 0 0 0 0 0 4 4 2017 (i)
Ateles marginatus 0 0 0 0 3 0 0 0 0 3 2013 (e)
Lagothrix cana 0 0 0 0 0 0 0 0 2 2 2017 (i)
Lagothrix sp. 0 0 0 0 2 0 0 0 0 2 2013 (e)
Callitrichidae (34)
Callithrix geoffroyi 0 0 0 0 0 0 0 0 1 1 2017 (i)
Callithrix jacchus 0 0 0 0 9 0 0 0 0 9 2013 (e)/2014 (e)/2016 (e)
Callithrix kuhlii 0 0 0 0 0 0 2 2 0 4 2012 (h)/2016 (g)
Callithrix penicillata 0 0 0 0 6 0 1 1 3 11 2012 (h)/2013 (e)/2016 (e, g)/2017 (i)
Callithrix sp. 0 0 0 0 0 0 1 0 0 1 2016 (g)
Leontopithecus chrysomelas 0 0 0 0 1 0 0 0 2 3 2013 (e)/2017 (i)
Leontopithecus rosalia 0 0 0 0 0 0 0 0 1 1 2017 (i)
Mico chrysoleucus 0 0 0 0 0 0 0 0 1 1 2017 (i)
Saguinus imperator 0 0 0 0 0 0 0 0 1 1 2017 (i)
Saguinus niger 0 0 0 0 0 0 0 0 2 2 2017 (i)
Cebidae (142)
Cebus albifrons 0 0 0 0 0 0 0 0 1 1 2017 (i)
Saimiri boliviensis 0 0 0 0 0 0 0 0 1 1 2017 (i)
Sapajus ﬂavius 0 0 21 0 7 0 1 0 0 29 2012 (c, g)/2013 (e)/2014 (c)
Sapajus libidinosus 0 0 0 0 1 0 1 2 2 6 2012 (h)/2016 (e, g)/2017 (i)
Sapajus nigritus 0 0 0 0 0 0 1 1 0 2 2012 (h)/2016 (g)
Sapajus robustus 0 0 0 0 1 0 2 0 0 3 2016 (e, g)
Sapajus sp. 0 1 0 0 41 10 21 0 0 73 2012 (a, e, f, g)/2013 (e)/2016 (e, g)
Sapajus xanthosternos 0 0 0 0 11 0 16 0 0 27 2012 (g)/2016 (e, g)
Pitheciidae (3)
Callicebus cupreus 0 0 0 0 0 0 0 0 1 1 2017 (i)
Chiropotes sagulatus 0 0 0 0 0 0 0 0 1 1 2017 (i)
Chiropotes satanas 0 0 0 0 0 0 0 0 1 1 2017 (i)
Total 1 2 21 1 82 10 47 6 37 207
aSampling sites are designated by letters as deﬁned in the legend to Fig. 1.
bsp., species in cases where morphological typing could not resolve species designation due to frequent hybridization events between different Latin American NHP
species (53, 54).
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Monotypic reactivity was observed in all 17 sera neutralizing either ZIKV or CHIKV,
suggesting that the observed reduction of ZIKV and CHIKV infectivity was not due to
potential nonspeciﬁc virucidal activity of the analyzed sera. However, plaque reduction
neutralization test (PRNT) endpoint titers were invariably low at a 1:40 serum dilution
FIG 1 Serological test results across sampling sites. (A) Map of South America with Brazilian regions from which samples originated; (B) locations of Brazilian
zoos, national primate centers, and cities in northeastern and central-western Brazilian states where the animals were sampled. Different colors denote positive
PRNT results for the viruses under study. Sampling sites are as follows: a, Lucena, Paraíba; b, Cabedelo, Paraíba; c, Santa Rita, Paraíba; d, Sapé, Paraíba; e, Salvador,
Bahia; f, Itapetinga, Bahia; g, Vitória da Conquista, Bahia; h, Barreiras, Bahia; i, Brasília, Federal District. The maps were created using QGIS2.14.3 (www.qgis.org).
Freely available map data were obtained from www.naturalearthdata.com and http://www.diva-gis.org/gdata.
TABLE 2 Details of individual samples testing positivea
Species
No. of animals positive by PRNT







siteZIKV YFV DENV CHIKV MAYV
A. belzebul 1 (1:40) Neg 1 (1:160) Neg NT 2014 1 b
S. ﬂavius 1 (1:40) Neg Neg NT NT 2014 21 c
S. ﬂavius NT NT NT 1 (1:40) Neg 2014 21
A. belzebul 1 (1:40) Neg 1 (1:40) Neg NT 2013 1 d
Ateles marginatus Neg NT NT 1 (1:40) 1 (1:40) 2013 3 e
C. jacchus Neg NT NT 1 (1:40) Neg 2013 8
Sapajus sp. Neg NT NT 2 (1:40) Neg 2013 37
S. xanthosternos Neg NT NT 2 (1:40) 1 (1:40) 2013 11
Sapajus sp. 1 (1:40) Neg Neg Neg NT 2012 21 g
S. robustus Neg NT NT 1 (1:40) Neg 2016 2
Sapajus sp. Neg NT NT 3 (1:40) Neg 2016 21
Callithrix penicillata 1 (1:40) Neg Neg Neg NT 2012 1 h
A. belzebul 1 (1:40) Neg Neg Neg NT 2017 3 i
aAbbreviations and designations: sp., species in cases where morphological typing could not resolve species
designation due to frequent hybridization events between different Latin American NHP species (53, 54);
Neg, negative; NT, not tested. Sampling sites are designated by letters as deﬁned in the legend to Fig. 1.
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for both ZIKV and CHIKV in all cases. For comparison, PRNT titers in ZIKV-infected
humans can be several orders of magnitude higher using the same PRNT protocol (37)
(Fig. 2A). Similarly, titers in NHP experimentally infected with ZIKV vary up to 4-fold after
seroconversion (Fig. 2B). The low titers that we observed may thus either represent a
lower magnitude of ZIKV- and CHIKV-speciﬁc antibody responses in New World NHP
than in humans or result from cross-reacting antibodies elicited by infection with
heterologous ﬂaviviruses or alphaviruses.
Cross-reactivity of antibodies in serological tests is commonly observed within the
genus Flavivirus (38, 39) and within Alphavirus serocomplexes (40) even when using
highly speciﬁc PRNTs, considered the gold standard for arbovirus serological testing.
The most relevant NHP-associated ﬂavivirus in Brazil is YFV, whereas the most relevant
human-associated ﬂavivirus in Brazil is DENV. CHIKV belongs to the Semliki Forest
serocomplex, which also includes Mayaro virus (MAYV), associated with NewWorld NHP
(41). Therefore, we performed PRNTs in all ZIKV-positive samples against YFV and DENV
and in the CHIKV-positive samples against MAYV. Two of six ZIKV-seropositive samples
(33.3%) neutralized DENV-1 at titers of 1:40 and 1:160 (Table 2). No ZIKV-seropositive
samples neutralized YFV. Two of the 11 CHIKV-seropositive samples (18.2%) also
neutralized MAYV at low titers of 1:40. Both animals neutralizing MAYV were sampled
in the same site in 2013 but belonged to different species, Sapajus xanthosternos and
Ateles marginatus. In sum, the serological reactivity patterns suggested that four of the
17 NHP that tested positive for either ZIKV or CHIKV (23.5%) were exposed to heter-
ologous alphaviruses or ﬂaviviruses.
Finally, ZIKV and CHIKV were likely introduced into different regions of northeastern
Brazil upon their arrival in mainland southern America in 2013. ZIKV was introduced to
the coastal region of northeastern Brazil, whereas CHIKV was introduced to the hinter-
land of northeastern Brazil (1, 2). Both ZIKV- and CHIKV-seropositive NHP were found
throughout mainland and coastal sampling sites in all sampling years except 2015
(Fig. 1). The geographic distribution of seropositive animals as early as 2013 thus did
not match the projected dispersal patterns of CHIKV and ZIKV.
DISCUSSION
Extensive spread of ZIKV and CHIKV in humans may cause population protective
immunity that causes the outbreaks to stop due to lack of acute cases (7). Persistence
of ZIKV in the blood of a few individuals for up to 2.5 months has been described (42),
and virus may persist in semen for up to 6 months (43). However, reports of prolonged
intrahost persistence are scarce, and probably, these isolated cases do not provide a
source of virus to allow reemergence on the population level. Cyclic reemergence in
humans is possible once a sufﬁcient number of susceptible individuals has become
available by birth or migration, such as has been documented for CHIKV in Africa and
Asia (44). The time needed for reemergence of urban cycles has been modeled for ZIKV
FIG 2 ZIKV-speciﬁc and CHIKV-speciﬁc PRNT endpoint titers in humans and nonhuman primates. (A)
ZIKV-speciﬁc PRNT endpoint titers in humans (n  122) as determined previously (37) using the same
PRNT protocol as in this study, suggesting comparability of results. One sample with a titer of 1:25,000
is not shown for graphical reasons. (B) ZIKV-speciﬁc (red) and CHIKV-speciﬁc (cyan) PRNT endpoint titers
from this study and from experimental ZIKV infections of New World nonhuman primates (35, 36).
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as 10 to 20 years (45) and documented to require several decades for CHIKV in the Old
World (46). Sylvatic transmission cycles may maintain ZIKV and CHIKV in the Americas
until reemergence in humans is possible.
We found limited evidence for exposure of NHP to ZIKV and CHIKV in urban and
peri-urban sampling sites in Brazil. On the one hand, our data may suggest that sylvatic
cycles involving Neotropical NHP are possible. Exposure of Brazilian NHP to ZIKV has
been suggested by the only preliminary report available to date, which showed a 30%
rate of acutely ZIKV-infected, i.e., real-time RT-PCR-positive, animals among peri-urban
Sapajus and Callithrix monkeys (28). The data from this preprint would be consistent
with the detection of seropositive animals belonging to the same NHP genera in this
study. However, ZIKV seroprevalence in Sapajus and Callithrix in our study ranged only
from 1.4% to 3.8%, which would imply much lower infection rates than those reported
in the preliminary study by Favoretto et al. (28) or high mortality of ZIKV-infected NHP,
which is not warranted by data from experimental infections (35, 36). Exposure of
Neotropical NHP to ZIKV and CHIKV would also be consistent with evidence for
infection with heterologous alphaviruses or ﬂaviviruses in only about 24% of seropos-
itive animals. Finally, the low antibody titers that we observed in the ﬁeld may be in
agreement with relatively low 80% PRNT (PRNT80) titers observed in experimental
infections of squirrel monkeys (Saimiri boliviensis and Saimiri sciureus), owl monkeys
(Aotus nancymaae), and marmosets (Callithrix jacchus) ranging from 1:80 to 1:320 after
seroconversion (35, 36). Our results may thus be consistent with exposure of NHP to
ZIKV as hypothesized before (26, 28).
On the other hand, ﬂaviviruses or alphaviruses other than those tested in this study may
have elicited cross-reactive antibodies weakly neutralizing ZIKV and CHIKV at a 1:40 serum
endpoint dilution, including St. Louis encephalitis virus, West Nile virus, and Eastern and
Western equine encephalitis viruses, all of which are known to cause sporadic spillover
infections in Neotropical NHP (47). Moreover, ZIKV-speciﬁc antibody titers were higher than
1:250 in 50% of tested humans using the same PRNT protocol (37), suggesting compara-
bility of PRNT results between humans and NHP and highlighting the relatively low
endpoint titers in NHP. Similarly, the fact that titers were invariably low and restricted to the
screening dilution of sera is striking. Normally, PRNT titers should vary on the population
level, and they do so in experimental infections and in human cohorts (37). Importantly, the
generally low seroprevalence and the absence of an increase in seroprevalence over time
are in stark contrast with the intensive ZIKV spread in humans in the same areas, reaching
about 60% during 2015 to 2016 in one of the sampling sites of this study (7). Seropreva-
lence in our study was also lower than that observed in African NHP, at around 16% for ZIKV
and 13% for CHIKV (10, 48). Consistently low antibody titers in all seropositive NHP,
evidence for possible cross-reactivity in 24% of the ZIKV- and CHIKV-positive sera, and
geospatial distribution of positive animals would thus speak against widespread ZIKV or
CHIKV infection in Brazilian NHP.
The strengths of our study include the broad sampling of different NHP species, the
broad timespan covering the epidemic spread of ZIKV and CHIKV, and the usage of
quantitative tools and several heterologous viruses that allowed an evaluation of the
speciﬁcity of the observed antibody responses. Limitations of our study include the
restricted geographical coverage and an irregular number of samples and species tested
per site. We thus cannot exclude more frequent exposure of NHP to ZIKV and CHIKV in
areas other than those sampled in this study in general and in remote areas in particular,
and we cannot exclude that sylvatic transmission cycles are possible in Latin America. That
sylvatic transmission cycles are possible in principle is illustrated by the high vector
competence of mosquitoes sustaining YFV sylvatic transmission cycles in Neotropical
regions for CHIKV (24) and by the susceptibility of different Neotropical NHP to ZIKV during
experimental infections (35, 36). Notably, the relevance of NHP for potential ZIKV or CHIKV
transmission cycles is highlighted by the lack of signiﬁcant levels of viremia in numerous
nonprimate animals following experimental infections with ZIKV and CHIKV (49, 50).
In sum, we found limited evidence for exposure of urban and peri-urban Neotropical
NHP to ZIKV and CHIKV. Our pioneering data may be interpreted as evidence for the
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exposure of NHP to these emerging arboviruses, which would be consistent with the
preliminary data available on this matter (26, 28, 36). However, deﬁnite conclusions on
the establishment of ZIKV sylvatic transmission cycles are not warranted by our data,
given the overall much lower titers of neutralizing antibodies and lower seroprevalence
in NHP than in humans (7, 37). Since establishment of sylvatic cycles would change the
fate of ZIKV and CHIKV in the Americas, samples that are geographically representative
and cover the large genetic diversity of Neotropical NHP are urgently needed. Because
sampling of NHP in the wild is restricted for ethical and ﬁnancial reasons (51), multi-
center studies joining groups and animal samples in analogy to prospective cohort
studies investigating congenital Zika disease in humans (52) would be highly desirable.
If indeed NHP were not involved in sylvatic transmission cycles in Latin America, other
wildlife or peri-domestic animals might ﬁll this ecological niche, highlighting the
relevance of targeted epidemiological investigations of Neotropical animals for infec-
tion with ZIKV and CHIKV.
MATERIALS AND METHODS
Sampling and ethical clearance. Animals were captured with nets and tranquilized using an
intramuscular application of ketamine hydrochloride (50 mg/ml, equivalent to 12 to 20 mg/kg of body
weight; BioChimico, Germany) and midazolam (5 mg/ml, equivalent to 0.04 to 0.4 mg/kg; Hipolabor,
Brazil). After clinical examination, up to 5 ml of blood was collected from the lateral or jugular saphenous
veins by a trained veterinarian. Animals were classiﬁed according to morphological characteristics such
as hair color and size by trained biologists. Sampling and export were approved by Brazilian and German
authorities (permit numbers: SISBio/ICMBio, 20610-5/20610-6 and no. 43737-5; Brazilian Ministry of
Agriculture, Livestock and Supplies [MAPA], no. 005/2014 and 001/2017; Ethics Committee of the School
of Veterinary Medicine of the Federal University of Bahia [CEUA/UFBA], no. 19/2011 and 57/2016;
CITES/Brazil, no. 14BR014818/DF and 16BR022343/DF; CITES/Germany, no. E-05004/E00306/17 and
E00307/17).
Laboratory analyses. All samples were analyzed for viral RNA using broadly reactive nested RT-PCR
assays targeting the Flavivirus and Alphavirus genera (29, 30), as well as highly speciﬁc real-time RT-PCR
assays for ZIKV (31) and CHIKV (32). Serological assays encompassed plaque reduction neutralization tests
(PRNTs) for ZIKV and CHIKV. All sera were heat inactivated (56°C, 30 min) prior to neutralization testing.
Brieﬂy, 2 l of serum was diluted in Dulbecco’s modiﬁed Eagle’s medium (DMEM) (containing 1% fetal
calf serum) at 1:40 and incubated with 50 plaque-forming units (PFU) of ZIKV (outbreak strain H/PF/2013,
Asian lineage, of French Polynesian origin, isolated in 2013) or CHIKV (strain 899, Indian Ocean lineage,
of Mauritian origin, isolated in 2006) at 37°C for 1 h. The preincubated virus-serum mixture was used to
infect Vero cells in 12-well plates. After incubation for 1 h at 37°C, an agarose-DMEM (containing 2% fetal
calf serum) overlay was added. Cells were incubated for 4 days for the ZIKV PRNT and for 2 days for the
CHIKV PRNT before formaldehyde ﬁxation and staining. Sera reducing viral PFU by 50% were consid-
ered positive. Positive sera were further diluted at 1:80, 1:160, 1:320, and 1:640 to determine endpoint
titers. Due to the cocirculation of antigenically related arboviruses that could elicit cross-reactive
antibodies in infected NHP, ZIKV-positive samples were further tested for antibodies against YFV (using
the vaccine strain 17D) and DENV-1 (strain 16007, of Thailand origin, isolated in 1964). CHIKV-positive
samples were further tested for antibodies against MAYV (strain TRVL15537, isolated in 1959 in Trinidad
and Tobago). Testing for neutralizing antibodies against YFV, DENV, and MAYV was done as described
above for the ZIKV PRNT, with the exception that BHK-J cells were used for YFV PRNTs. Incubation times
were 3 days for YFV and MAYV and 4 days for DENV.
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